Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Impact of Inducible, Replication-competent Latent HIV-1 as an Impediment to HIV/AIDS Cure in the Context of Sustained Viral Suppression

NCT04938518 is registered in ClinicalTrials.gov with Kenya Medical Research Institute as lead sponsor.

NCT NCT04938518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04938518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Impact of Inducible, Replication-competent Latent HIV-1 as an Impediment to HIV/AIDS Cure in the Context of Sustained Viral Suppression
Lead sponsor
Kenya Medical Research Institute
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2019
Completion date
April 30, 2022
Enrollment
222 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection